Published in Inflamm Bowel Dis on November 01, 2009
Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Ann Rheum Dis (2014) 1.00
Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.86
Optimizing the safety of biologic therapy for IBD. Nat Rev Gastroenterol Hepatol (2010) 0.85
Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis. Inflamm Bowel Dis (2015) 0.85
Prevention of infection caused by immunosuppressive drugs in gastroenterology. Ther Adv Chronic Dis (2013) 0.83
Updates in vaccination: recommendations for adult inflammatory bowel disease patients. World J Gastroenterol (2015) 0.82
Optimizing the Care and Health of Women with Inflammatory Bowel Disease. Gastroenterol Res Pract (2015) 0.81
Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression. Gastroenterol Hepatol (N Y) (2012) 0.79
Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal. Gastroenterol Res Pract (2015) 0.79
Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain. World J Gastroenterol (2013) 0.77
Use of thiopurines in inflammatory bowel disease: Safety issues. World J Gastrointest Pharmacol Ther (2014) 0.77
Cervical neoplasia risk in IBD: truth or hysteria? Inflamm Bowel Dis (2009) 0.77
Sex-Specific Issues in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2015) 0.75
Preventive health measures in inflammatory bowel disease. World J Gastroenterol (2016) 0.75
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis. Aliment Pharmacol Ther (2013) 3.33
Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut (1982) 3.23
New IBD genetics: common pathways with other diseases. Gut (2011) 2.95
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med (1980) 2.86
Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (1998) 2.83
Native nephrectomy in pediatric transplantation--less is more! J Pediatr Urol (2012) 2.67
Systematic review: The use of thiopurines or anti-TNF in post-operative Crohn's disease maintenance--progress and prospects. Aliment Pharmacol Ther (2014) 2.66
Interleukin 1 in Crohn's disease. Clin Exp Immunol (1987) 2.18
Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG (2008) 2.18
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients. Aliment Pharmacol Ther (2014) 2.11
Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit. Aliment Pharmacol Ther (2013) 2.01
Use of hand-held Doppler to identify 'difficult' forearm veins for cannulation. Ann R Coll Surg Engl (1995) 2.01
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut (2003) 1.95
NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun (2004) 1.94
Squamous cell carcinoma of the temporal bone: a radiographic-pathologic correlation. Arch Otolaryngol Head Neck Surg (2001) 1.94
Severe bilateral click. Br Dent J (2013) 1.91
Effect of heparin on polymerase chain reaction. Lancet (1994) 1.55
Mefenamic acid poisoning and epilepsy. Br Med J (1979) 1.54
Photometric detection of ATP release from human erythrocytes exposed to ultrasonically activated gas-filled pores. Ultrasound Med Biol (1980) 1.53
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut (2008) 1.53
Hemolysis near a transversely oscillating wire. Science (1970) 1.52
Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology (1997) 1.52
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer (1996) 1.51
Susceptibility loci in inflammatory bowel disease. Lancet (1996) 1.49
Adequacy of preoperative safety checks of the Bain breathing system. Br J Anaesth (1992) 1.41
Platelet aggregation induced in vitro by therapeutic ultrasound. Thromb Haemost (1977) 1.39
The modified bitegard: a method for administering supplemental oxygen and measuring carbon dioxide. Anesthesiology (1999) 1.39
Head protection in England before the first World War. Neurosurgery (2000) 1.39
Imaging microbubbles and tissues using a linear focussed scanner operating at 20 MHz: possible implications for the detection of cavitation thresholds. Ultrasonics (1991) 1.38
Hyaline globules in ovarian tumours. Histopathology (1993) 1.38
Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000. Aliment Pharmacol Ther (2011) 1.37
Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? Gut (2003) 1.35
IBD: a family affair. Best Pract Res Clin Gastroenterol (2004) 1.29
Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol (2004) 1.26
ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum Mol Genet (2006) 1.26
Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther (2001) 1.25
Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun (2000) 1.24
An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease. Aliment Pharmacol Ther (2003) 1.22
Cytokine gene polymorphisms in inflammatory bowel disease. Gut (1996) 1.21
The genetic jigsaw of inflammatory bowel disease. Gut (2002) 1.20
Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J Clin Endocrinol Metab (1999) 1.17
Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms. Br J Cancer (1985) 1.15
Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis. Am J Gastroenterol (2009) 1.15
Effect of using templates on the information included in histopathology reports on specimens of uterine cervix taken by loop excision of the transformation zone. J Clin Pathol (1999) 1.14
The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up. Aliment Pharmacol Ther (2009) 1.13
Expression of oestrogen receptor alpha and beta in cultured human ovarian surface epithelial cells. Mol Hum Reprod (1998) 1.12
DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population. Gut (2005) 1.12
The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther (2006) 1.11
Intravascular mural thrombi produced by acoustic microstreaming. Ultrasound Med Biol (1977) 1.11
p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status. Br J Cancer (1994) 1.11
Endometrial inhibin/activin beta-B subunit expression is related to decidualization and is reduced in tubal ectopic pregnancy. J Clin Endocrinol Metab (2008) 1.11
Endoscopic ultrasonography in the diagnosis and management of suspected upper gastrointestinal submucosal tumours. Br J Surg (2002) 1.09
Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women. Obstet Gynecol (1982) 1.09
Expression of COX-2 and PGE synthase and synthesis of PGE(2)in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br J Cancer (2001) 1.09
Inflammatory bowel disease and the X chromosome. QJM (1996) 1.08
Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther (2004) 1.07
Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: analysis of nationwide experience in Scotland (2004-2008). Aliment Pharmacol Ther (2009) 1.06
Endometrial cysteine-rich secretory protein 3 is inhibited by human chorionic gonadotrophin, and is increased in the decidua of tubal ectopic pregnancy. Mol Hum Reprod (2009) 1.06
Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria. Cochrane Database Syst Rev (2006) 1.06
Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome. Gastroenterology (2001) 1.05
Editorial: Early corticosteroids in ulcerative colitis. Aliment Pharmacol Ther (2014) 1.05
Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther (2004) 1.04
Release of serotonin from human platelets by acoustic microstreaming. J Acoust Soc Am (1974) 1.03
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev (2005) 1.01
Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010. QJM (2007) 1.01
The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease. Am J Hum Genet (2000) 1.01
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis. Aliment Pharmacol Ther (2007) 1.01
IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. Gut (2007) 1.01
A longitudinal study of HPV detection and cervical pathology in HIV infected women. Sex Transm Infect (2000) 1.00
Misuse of ecstasy. BMJ (1992) 1.00
Effects of the bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice. Pain (1997) 0.99
Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J Viral Hepat (2001) 0.99
Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients. J Cell Sci (2004) 0.99
Autophagy: from basic science to clinical application. Mucosal Immunol (2009) 0.98
Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern Europe. Inflamm Bowel Dis (2008) 0.98
Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis. Cochrane Database Syst Rev (2007) 0.97
Psychosocial interventions for smoking cessation in patients with coronary heart disease. Cochrane Database Syst Rev (2008) 0.97
Rosetting and other reactions of the Reed-Sternberg cell. J Pathol (1977) 0.97
Measurement of anomalously high hydration of (dA)n.(dT)n double helices in dilute solution. Nature (1989) 0.96
Effect of long-term treatment with low-dose mifepristone on the endometrium. Hum Reprod (2003) 0.96
Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut (2001) 0.95
Surgical morbidity associated with radical trachelectomy and radical hysterectomy. Gynecol Oncol (2005) 0.95
Target-controlled infusion in sleep endoscopy. Laryngoscope (2001) 0.95
Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as water-soluble prodrugs. J Med Chem (2000) 0.94
Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3. Hum Mol Genet (1999) 0.94
Inflammatory bowel disease: progress toward a gene. Can J Gastroenterol (2000) 0.93
TTF-1 expression in primary ovarian epithelial neoplasia. Histopathology (2006) 0.93